SPHERA FUNDS MANAGEMENT LTD. 13D/13G Filings for Praxis Precision Medicines, Inc. (PRAX)

SPHERA FUNDS MANAGEMENT LTD. 13D and 13G filings for Praxis Precision Medicines, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-05
09:13 am
Sale
2023-12-3113GPRAXIS PRECISION MEDICINES INC
PRAX
SPHERA FUNDS MANAGEMENT LTD.328,986
3.740%
-255,303decrease
(-43.69%)
Filing
2023-06-27
10:01 am
Unchanged
2023-06-1613GPRAXIS PRECISION MEDICINES INC
PRAX
SPHERA FUNDS MANAGEMENT LTD.584,289
7.350%
0
(Unchanged)
Filing
2023-06-22
11:26 am
Purchase
2023-06-1613GPRAXIS PRECISION MEDICINES INC
PRAX
SPHERA FUNDS MANAGEMENT LTD.584,289
7.310%
584,289increase
(New Position)
Filing